Text Size
372 studies found for:    "Benzoates"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Effects of a Food Preservative on Glucose Homeostasis
Condition: Overweight
Interventions: Other: benzoate containing test drinks;   Other: non sodium benzoate containing test drinks
2 Withdrawn Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
3 Recruiting Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Conditions: Obstructive Sleep Apnea;   Enlargement of Tonsil or Adenoid
Interventions: Drug: Caffeine and sodium Benzoate 10 mg/kg IV;   Drug: Caffeine and Sodium Benzoate 20 mg/kg IV;   Drug: 0.9 NS Saline
4 Completed
Has Results 		Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)(COMPLETED)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
5 Completed
Has Results 		Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Condition: Migraine Disorders
Interventions: Drug: rizatriptan benzoate (5 mg);   Drug: rizatriptan benzoate (10 mg);   Drug: Rizatriptan 5 mg Placebo;   Drug: Rizatriptan 10 mg Placebo
6 Completed Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors
Interventions: Drug: Sodium Benzoate;   Drug: Sodium Phenylacetate;   Drug: Sodium Phenylbutyrate;   Behavioral: Dietary Intervention
7 Completed
Has Results 		A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Condition: Acute Migraine With or Without Aura in Adolescents
Intervention: Drug: rizatriptan benzoate
8 Completed
Has Results 		A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Condition: Migraine
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: placebo
9 Completed
Has Results 		Treatment of Multiple Attacks of Acute Migraine
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
10 Completed
Has Results 		Study to Test Rizatriptan in the Early Treatment of Acute Migraine
Condition: Migraine
Interventions: Drug: Comparator: rizatriptan benzoate;   Drug: Comparator: Placebo
11 Completed
Has Results 		MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)(COMPLETED)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
12 Completed
Has Results 		MK0462 in Treatment of Migraine With Recurrence (MK0462-022)(COMPLETED)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: placebo
13 Completed Study to Test an Approved Product in the Early Treatment of Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
14 Completed Study to Test a Marketed Drug in the Treatment of Menstrual Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment -1 day;   Drug: Comparator: placebo / Duration of Treatment - 1 day
15 Completed Study to Test a Marketed Drug in the Treatment of Menstrual Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment -1day;   Drug: Comparator: placebo / Duration of Treatment - 1 day
16 Completed Study to Test an Approved Product in the Early Treatment of Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
17 Completed
Has Results 		Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
Conditions: Cancer;   Pain
Interventions: Drug: Caffeine;   Drug: Normal saline
18 Completed A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)
Condition: Healthy
Interventions: Drug: HPN-100;   Drug: Ammonul;   Drug: Buphenyl
19 Completed
Has Results 		The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
Conditions: Sleep Apnea, Obstructive;   Tonsillectomy;   Adenoidectomy;   Postoperative Complications
Interventions: Drug: Caffeine;   Drug: Placebo
20 Completed
Has Results 		Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
Condition: Hot Flashes
Interventions: Drug: Estradiol transdermal one 90 μL spray;   Drug: Estradiol transdermal spray, two 90 μL sprays;   Drug: Estradiol transdermal three 90 μL sprays;   Drug: Placebo transdermal two 90 μL sprays;   Drug: Placebo transdermal three 90 μL sprays;   Drug: Placebo transdermal one 90 μL spray
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years